NCT02552017

Brief Summary

The purpose of this study is to determine if a new device, called the Endocuff Vision (a small plastic device attached to the end of the colonoscope which helps by holding the folds of the bowel back to give a clear view of the inside of the bowel) will significantly improve the detection of adenomas when used in all patients referred for colonoscopy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,772

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

7 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

September 16, 2015

Status Verified

September 1, 2015

Enrollment Period

1.6 years

First QC Date

September 10, 2015

Last Update Submit

September 15, 2015

Conditions

Keywords

adenoma detection rateEndocuffEndocuff Visioncolonoscopybowel cancer screeningbowel cancer

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rate

    A difference in adenoma detection rate between Endocuff Vision-assisted colonoscopy and standard colonoscopy.

    10 months

Secondary Outcomes (10)

  • Mean adenomas detected per procedure

    10 months

  • Rate of cuff exchange

    10 months

  • Effect on duration of caecal intubation rates

    10 months

  • Patient satisfaction using validated patient comfort Bowel Cancer Screening Programme (BCSP) questionnaires

    10 months

  • Increase in surveillance colonoscopies caused by increased adenoma detection rate

    10 months

  • +5 more secondary outcomes

Study Arms (2)

Endocuff Vision-assisted Colonoscopy

ACTIVE COMPARATOR

Participants in this arm undergo Endocuff Vision-assisted colonoscopy

Device: Endocuff Vision

Standard Colonoscopy

NO INTERVENTION

Participants in this arm undergo standard colonoscopy

Interventions

Endocuff Vision is a new device made of soft plastic material with a unique dynamic shape. It is manufactured by ARC Medical Design Limited and Diagmed in the United Kingdom. It has European Conformity in United Kingdom. The core is made of polypropylene and the 'finger like' projections are made of a thermoplastic elastomer. It comes in four colour coded sizes (purple, blue, green and orange) to fit a range of paediatric and adult colonoscopes. Endocuff Vision is the more updated version of device that has only one proximal row of more rounded finger-like projections. It is mounted at the tip of the colonoscope and held on by friction (pull-off force is a minimum of 10 Newtons).

Endocuff Vision-assisted Colonoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients referred for screening, surveillance, or diagnostic colonoscopy
  • All patients must be able to give informed consent

You may not qualify if:

  • Patients with any absolute contraindications to colonoscopy
  • Patients with established or suspicion of large bowel obstruction or pseudo-obstruction
  • Patients with known colon cancer or polyposis syndromes
  • Patients with known colonic strictures
  • Patients with known severe diverticular segments (that is likely to impede colonoscope passage)
  • Patients with active colitis (ulcerative colitis, Crohn's colitis, diverticulitis, infective colitis)
  • Patients lacking capacity to give informed consent
  • Pregnancy
  • Patients who are on clopidogrel, warfarin, or other new generation anticoagulants who have not stopped this for the procedure.
  • Patients who are attending for a therapeutic procedure or assessment of a known lesion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

County Durham and Darlington NHS Foundation Trust

Durham, County Durham, DL3 6HX, United Kingdom

RECRUITING

North Tees and Hartlepool NHS Foundation Trust

Stockton-on-Tees, County Durham, TS19 8PE, United Kingdom

RECRUITING

St Mark's Hospital and Academic Institute

Harrow, Middlesex, HA1 3UJ, United Kingdom

RECRUITING

South Tees Hospitals NHS Foundation Trust

Middlesbrough, North Yorkshire, TS4 3BW, United Kingdom

RECRUITING

Northumbria Healthcare NHS Foundation Trust

North Shields, Tyne and Wear, NE29 8NH, United Kingdom

RECRUITING

South Tyneside NHS Foundation Trust

South Shields, Tyne and Wear, NE34 0PL, United Kingdom

RECRUITING

City Hospitals Sunderland NHS Foundation Trust

Sunderland, Tyne and Wear, SR4 7TP, United Kingdom

RECRUITING

Related Publications (1)

  • Ngu WS, Bevan R, Tsiamoulos ZP, Bassett P, Hoare Z, Rutter MD, Clifford G, Totton N, Lee TJ, Ramadas A, Silcock JG, Painter J, Neilson LJ, Saunders BP, Rees CJ. Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial. Gut. 2019 Feb;68(2):280-288. doi: 10.1136/gutjnl-2017-314889. Epub 2018 Jan 23.

MeSH Terms

Conditions

Colorectal NeoplasmsColonic PolypsAdenomaIntestinal Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesIntestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Officials

  • Colin Rees, MBBS, FRCP

    South Tyneside and Sunderland NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wee Sing Ngu, MBChB, MRCS

CONTACT

Gayle Clifford, BSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2015

First Posted

September 16, 2015

Study Start

November 1, 2014

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

September 16, 2015

Record last verified: 2015-09

Locations